Health Care

Amgen Inc. (NASDAQ: AMGN) has reported lower revenues and adjusted earnings for the first quarter of 2023. The biotechnology firm…

Gilead Sciences, Inc. (NASDAQ: GILD) reported total revenue of $6.4 billion for the first quarter of 2023, which was down…

Eli Lilly and Company (NYSE: LLY) Q1 2023 earnings call dated Apr. 27, 2023 Corporate Participants: Joe Fletcher -- Senior Vice President…

Biotechnology company Bristol Myers Squibb (NYSE: BMY) said its first-quarter adjusted earnings increased modestly, despite a decline in revenues. Net…

Pharma firm Merck & Co., Inc.  (NYSE: MRK) on Thursday reported lower earnings for the first quarter of 2023, due to…

Eli Lilly and Company (NYSE: LLY) on Thursday reported lower earnings and revenues for the first quarter of 2023. The…

Amgen Inc.  (NASDAQ: AMGN) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Arvind Sood — Vice President, Investor Relations Robert…

Biopharmaceutical company Ocean Biomedical (NASDAQ: OCEA) on Thursday said its scientific co-founder Jack Elias published new findings in Cancer Research,…

Merck & Co., Inc. (NYSE: MRK) Q1 2023 Earnings Call dated Apr. 27, 2023 Corporate Participants: Peter Dannenbaum -- Vice President, Investor…

Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a decrease in first-quarter 2023 adjusted earnings and revenues. The company also provided…